These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 433175)
21. The physiologic basis for therapy of classic hemophilia (factor 8 deficiency) and related disorders. Combined clinical staff conference at the National Institutes of Health. Ann Intern Med; 1967 Oct; 67(4):856-82. PubMed ID: 5299081 [No Abstract] [Full Text] [Related]
22. [Treatment of hemorrhage in a patient with severe hemophilia A and factor VIII antibodies]. Gassmann AE; Kerkhofs H; Leeksma CH Schweiz Med Wochenschr; 1970 Oct; 100(41):1734-6. PubMed ID: 5480542 [No Abstract] [Full Text] [Related]
23. Management of hemophilia in Spain. Martin-Villar J; Ortega F; Magallon M Thromb Haemost; 1976 Jun; 35(3):537-43. PubMed ID: 989959 [TBL] [Abstract][Full Text] [Related]
24. [Long-term treatment of hemophilia A with plasma fractions]. Mey U; Gaerisch F Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):357-62. PubMed ID: 4195282 [No Abstract] [Full Text] [Related]
27. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia. McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730 [TBL] [Abstract][Full Text] [Related]
28. The management of haemophilia. Rizza CR Practitioner; 1970 Jun; 204(224):763-72. PubMed ID: 5452203 [No Abstract] [Full Text] [Related]
29. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate]. Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915 [No Abstract] [Full Text] [Related]
30. [Epidemiology and characteristics of hemophilia in Bulgaria]. Anastassov A; Tankovski I; Nigno C; Guénova V; Lissitchkov T Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):113-8. PubMed ID: 4110776 [No Abstract] [Full Text] [Related]
31. [Prophylactic replacement therapy in hemophilia. A case report (author's transl)]. Mitterstieler G Padiatr Padol; 1976; 11(2-2):469-74. PubMed ID: 967509 [TBL] [Abstract][Full Text] [Related]
32. Treatment of haemophilia with purified factor 8 (FI-O-Ta). de Tezanos Pinto M Hemostase; 1966; 6(1):65-71. PubMed ID: 5911788 [No Abstract] [Full Text] [Related]
33. Estimation of the probability of post transfusion hepatitis in hemophilia treatment. Davis CE; Grizzle JE; Bryan JA Biometrics; 1973 Jun; 29(2):386-92. PubMed ID: 4709517 [No Abstract] [Full Text] [Related]
39. A method for the production of AHG rich cryoprecipitates & their use in the management of bleeding episodes in haemophilia. Kwa SB; Chen YF Singapore Med J; 1968 Mar; 9(1):12-6. PubMed ID: 5659889 [No Abstract] [Full Text] [Related]
40. [A case of neonatal hemophilia A with massive subneural hemorrhage]. Barbero S; Cordero A; Domeneghetti G; Giaccardi A; Sardi R; Serra A Minerva Pediatr; 1980 Jun; 32(12):815-7. PubMed ID: 6780779 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]